|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 79.22 USD | +0.81% |
|
+0.42% | +0.35% |
| 13/02 | Mizuho Adjusts Price Target on MetLife to $100 From $102, Maintains Outperform Rating | MT |
| 12/02 | Evercore ISI Adjusts Price Target on MetLife to $95 From $97, Maintains In Line Rating | MT |
| Capitalization | 51.97B 43.98B 40.12B 38.36B 71.06B 4,714B 73.53B 468B 185B 2,274B 195B 191B 8,022B | P/E ratio 2025 |
16.8x | P/E ratio 2026 * | 8.76x |
|---|---|---|---|---|---|
| Enterprise value | 51.97B 43.98B 40.12B 38.36B 71.06B 4,714B 73.53B 468B 185B 2,274B 195B 191B 8,022B | EV / Sales 2025 |
0.66x | EV / Sales 2026 * | 0.66x |
| Free-Float |
47.69% | Yield 2025 * |
2.83% | Yield 2026 * | 2.96% |
Last Transcript: MetLife, Inc.
| 1 day | +0.81% | ||
| 1 week | +0.42% | ||
| Current month | +0.43% | ||
| 1 month | +3.19% | ||
| 3 months | +5.11% | ||
| 6 months | +1.90% | ||
| Current year | +0.35% |
| 1 week | 76.14 |  | 79.68 |
| 1 month | 74.88 | | 81.67 |
| Current year | 74.88 | | 83 |
| 1 year | 65.21 | | 87.39 |
| 3 years | 48.95 | | 89.05 |
| 5 years | 48.95 | | 89.05 |
| 10 years | 22.85 | | 89.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michel Khalaf
CEO | Chief Executive Officer | 62 | 01/05/2019 |
John McCallion
DFI | Director of Finance/CFO | 52 | 01/05/2018 |
William Pappas
COO | Chief Operating Officer | 44 | 19/11/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Hubbard
CHM | Chairman | 66 | 01/02/2007 |
Michel Khalaf
BRD | Director/Board Member | 62 | 01/05/2019 |
Carlos Gutierrez
BRD | Director/Board Member | 72 | 08/03/2013 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +0.53% | 1.32% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.81% | +0.42% | -3.89% | +9.21% | 51.49B | |
| -1.88% | -3.27% | +27.25% | +33.79% | 168B | |
| -0.03% | +2.54% | +3.25% | +36.80% | 91.87B | |
| 0.00% | +3.74% | +10.36% | +95.36% | 63.33B | |
| -0.18% | -1.48% | +18.96% | +87.07% | 62.29B | |
| -1.04% | -2.26% | +8.98% | +63.79% | 59.87B | |
| -1.61% | -3.23% | +31.16% | +58.15% | 55.76B | |
| +0.27% | +4.87% | +22.05% | +73.38% | 41.8B | |
| +2.04% | -3.19% | +54.72% | -13.93% | 37.61B | |
| -1.76% | +3.15% | +15.26% | +31.82% | 37.5B | |
| Average | -0.34% | -0.63% | +18.81% | +47.55% | 66.96B | |
| Weighted average by Cap. | -0.62% | -1.39% | +18.43% | +47.48% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 85.47B 72.33B 65.98B 63.09B 117B 7,752B 121B 769B 305B 3,740B 321B 314B 13,194B | 78.98B 66.84B 60.97B 58.3B 108B 7,164B 112B 711B 282B 3,456B 296B 290B 12,192B |
| Net income | 3.82B 3.23B 2.95B 2.82B 5.22B 346B 5.4B 34.34B 13.6B 167B 14.31B 14.02B 589B | 5.85B 4.95B 4.51B 4.32B 8B 530B 8.27B 52.62B 20.85B 256B 21.93B 21.48B 903B |
| Net Debt | - | - |
Employees
45,000
Sector
Life & Health Insurance
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/02/26 | 79.22 $ | +0.81% | 2,891,199 |
| 17/02/26 | 78.58 $ | +1.64% | 2,950,380 |
| 13/02/26 | 77.31 $ | -0.06% | 3,113,777 |
| 12/02/26 | 77.36 $ | -1.94% | 4,376,139 |
| 11/02/26 | 78.89 $ | +1.24% | 4,388,055 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
79.30USD
Average target price
91.73USD
Spread / Average Target
+15.67%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MET Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition